HOFSETH BIOCARE ASA: årsregnskap 2018 vs 2017
Shrank 47% on revenue, weaker earnings
approved 2019-03-15; registry 2019-06-24; journal 2019 516794
Summary
What changed
Comparing Årsregnskap 2018 with 2017 for HOFSETH BIOCARE ASA. Revenue 94.54m NOK → 49.88m NOK (-47.2%). Net result -36.17m NOK → -84.77m NOK. Equity 37.68m NOK → 87.45m NOK.
On the constructive side: equity strengthened; cash rose. Pressures included: revenue fell; net result weakened; payroll up without matching revenue.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 37.68m NOK → 87.45m NOK (equity ratio 18567.5% → 672723076.9%). Calculated
-
↑
Cash rose
Bank deposits 40.98m NOK → 45.29m NOK (+10.5% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 94.54m NOK to 49.88m NOK (-47.2% YoY). Calculated
-
↓
Net result weakened
Net result -36.17m NOK → -84.77m NOK (net margin -38.3% → -169.9%). Calculated
-
↓
Payroll up without matching revenue
Salary cost 21.02m NOK → 25.02m NOK (22% → 50% of revenue). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 37.68m NOK → 294.8k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 29.61m NOK → 25.31m NOK. Reported fact